Full Breakdown
Rocket Lab Stock Outlook After Neutron Test Setback
9/9/2026, 7:27:38 PM
Recent Performance and Analyst Targets
Rocket Lab’s shares are trading around $64.26, well below the Wall Street average price target of $111, which translates to an implied upside of roughly 72.7% (source). Stifel analyst Erik Rasmussen assigns a “Street-high” target of $150, a level that would more than double the current price (source). Over the past month the stock fell 14.11%, while the S&P 500 was essentially flat (source). Year-to-date the shares are down 7.88% versus a 12.94% gain for the broader index, yet a one-year view still shows a 49.48% increase (source).
Backlog Strength and Defense Contracts
Rocket Lab ended the second quarter with a record $2.36 billion backlog, up 137% year over year, and management indicated more than $1 billion of new contracts signed in the current quarter (source). The defense pipeline includes a $397 million Flatellite contract for the Space Force SB-AMTI program, an $816 million SDA Tracking Layer Tranche 3 award, and work on the Golden Dome Space-Based Interceptor program with Raytheon (source). FY2027 Department of Defense budgeting allocates $71.2 billion to the U.S. Space Force, providing a growth vector for space primes (source).
Management Outlook and Risks
Company leadership has said the Neutron medium-lift rocket’s first flight is now slated for the fourth quarter of 2026 after a Stage 1 tank test failure pushed the debut back (source). Management argues that a successful Neutron launch would make the Iridium acquisition rationale credible, accelerate backlog conversion, and potentially turn free cash flow positive within 18-24 months (source). Risks highlighted include additional test failures, integration challenges with Iridium, and continued dilution from a $1.53 billion at-the-market equity program raised in the first half of the year (source).
Outlook and Investor Considerations
Forward revenue estimates project $958 million for FY2026 and $1.36 billion for FY2027, though both years carry negative average EPS forecasts (source). The stock trades at more than 50 times sales, indicating a high valuation multiple that demands patience and a clear exit strategy (source). Analysts across the sector generally rate Rocket Lab as a Buy or Hold, with implied upside ranging from roughly 28% for AST SpaceMobile to nearly 99% for Intuitive Machines, positioning Rocket Lab in the mid-range of its peer group (source). The consensus view hinges on Neutron reaching the pad and delivering a clean flight; any further setbacks could erode the bullish thesis (source).
